MYC translocations and/or MYC protein overexpression are relatively frequent events in DLBCL (around 10% and 30% of cases, respectively) and, most importantly, have been linked to reduced patient survival [84, 85, 86, 87, 88]. Here, MYC is linked to diffuse large B-cell lymphoma.